1 Study Coverage
1.1 Prostate Cancer Treatment Drugs Revenue in Prostate Cancer Treatment Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Prostate Cancer Treatment Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Prostate Cancer Treatment Drugs Market Size for the Year 2017-2028
1.2.2 Global Prostate Cancer Treatment Drugs Market Size for the Year 2017-2028
1.3 Prostate Cancer Treatment Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Prostate Cancer Treatment Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Prostate Cancer Treatment Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Prostate Cancer Treatment Drugs Market Dynamics
1.4.1 Prostate Cancer Treatment Drugs Industry Trends
1.4.2 Prostate Cancer Treatment Drugs Market Drivers
1.4.3 Prostate Cancer Treatment Drugs Market Challenges
1.4.4 Prostate Cancer Treatment Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Prostate Cancer Treatment Drugs by Type
2.1 Prostate Cancer Treatment Drugs Market Segment by Type
2.1.1 Zytiga
2.1.2 Gonax
2.1.3 Lupron
2.1.4 Zoladex
2.1.5 Decapeptyl
2.1.6 Eligard
2.1.7 Vantas
2.1.8 Casodex
2.1.9 Others
2.2 Global Prostate Cancer Treatment Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Prostate Cancer Treatment Drugs Market Size by Type (2017-2028)
2.4 United States Prostate Cancer Treatment Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Prostate Cancer Treatment Drugs Market Size by Type (2017-2028)
3 Prostate Cancer Treatment Drugs by Application
3.1 Prostate Cancer Treatment Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Clinics
3.2 Global Prostate Cancer Treatment Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Prostate Cancer Treatment Drugs Market Size by Application (2017-2028)
3.4 United States Prostate Cancer Treatment Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Prostate Cancer Treatment Drugs Market Size by Application (2017-2028)
4 Global Prostate Cancer Treatment Drugs Competitor Landscape by Company
4.1 Global Prostate Cancer Treatment Drugs Market Size by Company
4.1.1 Top Global Prostate Cancer Treatment Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Prostate Cancer Treatment Drugs Revenue by Player (2017-2022)
4.2 Global Prostate Cancer Treatment Drugs Concentration Ratio (CR)
4.2.1 Prostate Cancer Treatment Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Prostate Cancer Treatment Drugs in 2021
4.2.3 Global Prostate Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Prostate Cancer Treatment Drugs Headquarters, Revenue in Prostate Cancer Treatment Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Prostate Cancer Treatment Drugs Headquarters and Area Served
4.3.2 Global Prostate Cancer Treatment Drugs Companies Revenue in Prostate Cancer Treatment Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Prostate Cancer Treatment Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Prostate Cancer Treatment Drugs Market Size by Company
4.5.1 Top Prostate Cancer Treatment Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Prostate Cancer Treatment Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Prostate Cancer Treatment Drugs Market Size by Region
5.1 Global Prostate Cancer Treatment Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prostate Cancer Treatment Drugs Market Size by Region (2017-2028)
5.2.1 Global Prostate Cancer Treatment Drugs Market Size by Region: 2017-2022
5.2.2 Global Prostate Cancer Treatment Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prostate Cancer Treatment Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Prostate Cancer Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prostate Cancer Treatment Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prostate Cancer Treatment Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Prostate Cancer Treatment Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Prostate Cancer Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prostate Cancer Treatment Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Prostate Cancer Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prostate Cancer Treatment Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prostate Cancer Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Details
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Introduction
7.1.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2017-2022)
7.1.5 Johnson & Johnson Recent Development
7.2 Astella
7.2.1 Astella Company Details
7.2.2 Astella Business Overview
7.2.3 Astella Prostate Cancer Treatment Drugs Introduction
7.2.4 Astella Revenue in Prostate Cancer Treatment Drugs Business (2017-2022)
7.2.5 Astella Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Details
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prostate Cancer Treatment Drugs Introduction
7.3.4 Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2017-2022)
7.3.5 Sanofi Recent Development
7.4 Ipsen
7.4.1 Ipsen Company Details
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Prostate Cancer Treatment Drugs Introduction
7.4.4 Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2017-2022)
7.4.5 Ipsen Recent Development
7.5 Bayer
7.5.1 Bayer Company Details
7.5.2 Bayer Business Overview
7.5.3 Bayer Prostate Cancer Treatment Drugs Introduction
7.5.4 Bayer Revenue in Prostate Cancer Treatment Drugs Business (2017-2022)
7.5.5 Bayer Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Details
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Prostate Cancer Treatment Drugs Introduction
7.6.4 AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2017-2022)
7.6.5 AstraZeneca Recent Development
7.7 Dendreon
7.7.1 Dendreon Company Details
7.7.2 Dendreon Business Overview
7.7.3 Dendreon Prostate Cancer Treatment Drugs Introduction
7.7.4 Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2017-2022)
7.7.5 Dendreon Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
